Online therapy for anxiety and depression in new mothers
Transdiagnostic Internet Cognitive-behavior Therapy for Mixed Anxiety and Depressive Symptoms in Postnatal Women
This study tests whether an online therapy program can help new mothers with anxiety and depression feel better when combined with their usual treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 226 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Université de Sherbrooke Academic / other |
| Locations | 4 sites (Châteauguay, Quebec and 3 other locations) |
| Trial ID | NCT06778096 on ClinicalTrials.gov |
What this trial studies
This project evaluates the effectiveness of a French-Canadian version of an internet-based cognitive behavioral therapy (iCBT) program designed for postnatal women experiencing anxiety and depressive symptoms. Participants will be randomly assigned to either receive the iCBT program alongside standard treatment or to a waitlist control group receiving standard treatment only. The study aims to assess symptom reduction through questionnaires administered before, after, and four weeks post-intervention. The research also seeks to identify barriers and facilitators for implementing this program on a larger scale.
Who should consider this trial
Good fit: Ideal candidates are women aged 18 and older who are within 12 months postpartum and fluent in French, with moderate anxiety or depressive symptoms.
Not a fit: Patients with severe depression, active suicidal intentions, or those with certain psychiatric diagnoses may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly reduce anxiety and depressive symptoms in postnatal women, improving their overall mental health and well-being.
How similar studies have performed: Previous studies have shown that internet-delivered cognitive behavioral therapy can be effective for treating anxiety and depression, suggesting a promising outlook for this adapted program.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years and older * Being within 12 months postpartum * Fluent in spoken and written French * Self-reported clinical score ≥10 for anxiety and/or depressive symptoms based on the Generalised Anxiety Disorder-7 (GAD-7) and the Edinburgh Postnatal Depression Scale 10-item scale (EPDS) * Access to a computer/tablet and internet connection * Agreement to share primary provider contact information Exclusion Criteria: * Self-reported diagnosis of schizophrenia or bipolar disorder * Current substance abuse or dependence * Current use of benzodiazepines * Beginning psychological therapy (\< 4 weeks ago) or medication (\< 8 weeks ago) for depression/anxiety * Severe depression (EPDS score ≥ 23) or active suicidal intentions (EPDS question 10 = 3, yes quite often)
Where this trial is running
Châteauguay, Quebec and 3 other locations
- Centre intégré de santé et services sociaux de la Montérégie-Ouest — Châteauguay, Quebec, Canada (Recruiting)
- Centre intégré de santé et services sociaux de la Montérégie-Est — Greenfield Park, Quebec, Canada (Recruiting)
- Centre intégré de santé et services sociaux de la Montérégie-Centre — Longueuil, Quebec, Canada (Recruiting)
- Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre hospitalier universitaire de Sherbrooke — Sherbrooke, Quebec, Canada (Recruiting)
Study contacts
- Principal investigator: Pasquale Roberge, PhD — Université de Sherbrooke
- Study coordinator: Pasquale Roberge, PhD
- Email: Pasquale.Roberge@USherbrooke.ca
- Phone: 819 821-8000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.